Figure 4: Dose response curves of the combination of L-canavanine (L-CAV) and doxorubicin (DOX), and L-canavanine (L-CAV) and cisplatin (CIS) for the growth inhibition of Hep G2 and SK-Hep-1, using a constant ratio method in arginine-free media (AFM).

(n.d.). Figure 4: Dose response curves of the combination of L-canavanine (L-CAV) and doxorubicin (DOX), and L-canavanine (L-CAV) and cisplatin (CIS) for the growth inhibition of Hep G2 and SK-Hep-1, using a constant ratio method in arginine-free media (AFM).. https://doi.org/10.7717/peerj.1542/fig-4

. "Figure 4: Dose response curves of the combination of L-canavanine (L-CAV) and doxorubicin (DOX), and L-canavanine (L-CAV) and cisplatin (CIS) for the growth inhibition of Hep G2 and SK-Hep-1, using a constant ratio method in arginine-free media (AFM).". CrossRef. doi:10.7717/peerj.1542/fig-4.

@article{jurnal2024, title = {Figure 4: Dose response curves of the combination of L-canavanine (L-CAV) and doxorubicin (DOX), and L-canavanine (L-CAV) and cisplatin (CIS) for the growth inhibition of Hep G2 and SK-Hep-1, using a constant ratio method in arginine-free media (AFM).}, journal = {CrossRef}, doi = {10.7717/peerj.1542/fig-4}, url = {https://doi.org/10.7717/peerj.1542/fig-4}, }

Figure 4: Dose response curves of the combination of L-canavanine (L-CAV) and doxorubicin (DOX), and L-canavanine (L-CAV) and cisplatin (CIS) for the growth inhibition of Hep G2 and SK-Hep-1, using a constant ratio method in arginine-free media (AFM).

Format Sitasi

Akses Cepat